Karin Jirström
- Therapeutic pathology
- Department Office of Clinical Sciences, Lund
- Tumor microenvironment
- Department of Clinical Sciences, Lund
- Personalized Pathology & Cancer Therapy
- Section V
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- LUCC: Lund University Cancer Centre
- Faculty of Medicine
1 – 10 of 348
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Prediction of post-treatment recurrence in early-stage breast cancer using deep-learning with mid-infrared chemical histopathological imaging
(
- Contribution to journal › Article
-
Mark
Genetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort
(
- Contribution to journal › Article
- 2024
-
Mark
AIRE is expressed in breast cancer TANs and TAMs to regulate the extrinsic apoptotic pathway and inflammation
(
- Contribution to journal › Article
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
(
- Contribution to journal › Article
-
Mark
Entropy-based spatial heterogeneity analysis in pathological images for diagnostic applications
2024) Data Science for Photonics and Biophotonics 2024 In Proceedings of SPIE - The International Society for Optical Engineering 13011.(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Preliminary evaluation of an automated autoencoder-UNet pipeline for chemical image segmentation and compression with reference to serial ground truth pathology
2024) Data Science for Photonics and Biophotonics 2024 In Proceedings of SPIE - The International Society for Optical Engineering 13011.(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
(
- Contribution to journal › Article
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
(
- Contribution to journal › Article
-
Mark
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition
(
- Contribution to journal › Article
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
(
- Contribution to journal › Article